Double-Blind, Placebo-Controlled, Multicenter, Randomized, Phase IIB Neoadjuvant Study of Letrozole-Lapatinib in Postmenopausal Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, Operable Breast CancerValentina Guarneri, PierFranco Conte, Daniele Generali et al.|Journal of Clinical Oncology|2014Cited by 62